98% Injectable Polypeptide Hormones IpamorelinCAS 170851-70-4 For Energy Homeostasis & Regulation Of Bodyweight

98% Injectable Polypeptide Hormones IpamorelinCAS170851-70-4 For Energy Homeostasis & Regulation Of Bodyweight

Quick Details :

Ipamorelin

Alias : 696: PN:WO2004005342 PAGE: 46claimed protein, Ipamorelin, NNC 26-0161

CAS: 170851-70-4

Formula: C38H49N9O5

MW:711.853

MS :

Appearance: White powder

Grade : Pharmaceutical Grade

Manufacturer: Hezhong

purity:99%min

Usage :Growth hormone secretagoguereceptor is a G protein-coupled receptorthat binds ghrelin and plays a role inenergy homeostasis and regulation of bodyweight.

Description:

Ipamorelinisa fascinating new muscle building discovery that is getting a lot of attentionin the bodybuilding world. Like the GHRP-6 peptide (growth hormone releasinghexapeptide), it is a synthetic peptide that has powerful Growth Hormonereleasing properties. And these GH releasing properties are what is of interestto athletes and bodybuilders since they can make a tremendous difference in theamount of muscle you can grow and how quickly you burn fat.

Application :

Ipamorelinis an interesting peptide taken 300mcg twice daily or you could lower the dosefor 3 times daily, side effects are head rushs, I would recommend taking this30 minutes before workout ,with gear, Ipamorelin is a new and potent syntheticpentapeptide which has distinct and specific growth hormone (GH)-releasingproperties. With the objective of investigating the effects on longitudinalbone growth rate , body weight , and GH release, Ipamorelin in different doses(0, 18, 90 and 450 μg/day) was injected three times dailyfor 15 days to test subjects, After intravital Tetracycline labelling on days0, 6, and 13, LGR was determined by measuring the distance between therespective fluorescent bands in the proximal tibia metaphysis. Ipamorelindose-dependently increased LGR from 42 μm/dayin the vehicle group to 44, 50, and 52 μm/dayin the treatment groups . There was also a pronounced and dose-dependent effecton body weight gain. The treatment did not affect total IGF-I levels, or serummarkers of bone formation and resorption. The number of tartrate-resistant acidphosphatase-positive multinuclear cells in the metaphysis of the tibia did notchange significantly with treatment. The responsiveness of the pituitary to aprovocative i.v. dose of Ipamorelin or GHRH showed that the plasma GH responsewas marginally reduced , after Ipamorelin, but unchanged after GHRH. Thepituitary GH content was unchanged by Ipamorelin treatment. Whether Ipamorelinor other GH secretagogues may have a place in the treatment of children withgrowth retardation requires demonstration in future clinical studies. Beforeclosing Ipamorelin is the most selective GH releaser you can get.
Ipamorelin doesn't create bumps in either prolactin or cortisol like GHRP-2 and-6. Ipa is a rifle bullet, not a shotgun blast like other GHRP's. Also it'sgreat for those on relatively calorie restricted diets because it doesn'tstimulate appetite
Ipamorelin and Peptides are the way of the future ,expect in the next 5 yearsor less a dramatic change in the way we train and take the bodybuilding worldby storm.